Myeloma
-
Policy Matters
Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials
The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.
by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD
-
Forward Look
Learning How to Prevent Multiple Myeloma
Irene Ghobrial on studying cancer precursors.
by Sue Rochman
-
Survivor Profile
A Long Road Back
Multiple myeloma survivor Gary Lambert deploys inventiveness and fortitude to deal with cancer.
by Lindsey Konkel
-
Vaccines: Looking Within for Cancer Treatment
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
-
Treatment Is Waiting
For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
-
Yesterday & Today
Taking Her Place
Geraldine Ferraro, the first woman nominated for vice president on a major-party ticket, used her political prowess to advocate for women's equality. In 1998, she was diagnosed with multiple myeloma.
by Sharlene George
-
Forward Look
African-Americans at Higher Risk for Multiple Myeloma
Researchers aim to identify possible reasons.
by Sue Rochman
-
Forward Look
Paying a Steep Price
New laws are pushing health insurers to make oral cancer drugs affordable.
by Betty Russell